Malaria PF(HRP2)/PV Antigen test
Introduction:
- Malaria is a parasitic disease transmitted to humans through the bite of four species of female Anopheles mosquitoe, Plasmodium falciparum, P. vivax, P. Ovale, and P. Malariae.
- It is preventable and curable.
- In 2020, there were an estimated 241 million cases of malaria worldwide.
- The Africa and south east Asia carries a disproportionately high share of the global malaria burden.
- Malaria is a serious parasitic disease characterized by fever, chills and anemia.
Intended Use:
- Test for qualitative detection of ChikungunyaIgG/IgM in human serum, plasma and whole blood samples.
- pLDH (Plasmodium Lactate Dehydrogenase) and HRP2 (Histidine Rich Protein 2) are the important markers for diagnosis of Malaria infections.
- pLDH and HRP2 both are used as antigen based diagnosis of Malaria infections and we use antibodies against these markers in our products for detecting these antigens in Human whole Blood.
Product specifications:
| Pack Sizes | 25 Test 50 Test |
|---|---|
| Kit components | Test Device. Assay Buffer. Instructions for Use |
| Test Procedure | Qualitative only |
| Sample Type | Whole Blood only collected in EDTA, Heparin or Citrate anticoagulants |
| Kit dimensions | 25 test – 75x150x110 mm. 50 test – 75x275x135 mm. |
| Approx. weight of kit | 25 test – 150 gms. 50 test – 300 gms. |
| Storage Temperature | Room Temperature |
| Shelf life | 24 months |
| Production Capacity | 50 mn ml per annum |